New York · Nonprofit
ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC
ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC (New York) receives grants from 202 organizations whose IRS filings report $9,875,540 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($1,402,243). 86 of them have funded it in more than one year.
- Revenue FY2025
- $5.8M
- Funders on record
- 202
- Grants received
- $9.9M
- Net assets
- $7.3M
What Alzheimer's Disease and Related Disorders New York City Inc does
Mission
To create, deliver, and promote comprehensive and compassionate care and support services for individuals and families affected by alzheimer's disease and related dementias, and to eliminate alzheimer's disease through the advancement of research.
As stated on its FY2025 Form 990.
Programs
Family support and education: the goal of the family supports & education department is to be a trusted partner ready to help clients living with alzheimer's or other cognitive disorders and family care partners as they are going through this journey. The department is responsible for multiple services including: helpline, care consultations and coaching, support groups, and education programs. Our aim is to provide the support, education, tools, and resources that diagnosed individuals and their care partners need to navigate their situations and to equip them with the right questions to ask.
$1,695,988 spentof which $189,892 as grants$44,830 earned by the program38% of program spendingEarly-stage & engagement services: for individuals in the early stages of alzheimer's and related dementias, caringkind offers programs designed to engage and support them through small group programs. These services aim to help individuals maintain stimulation, foster social connections, and enhance overall well-being.
$1,055,640 spentof which $22,141 as grants$1,515 earned by the program23% of program spendingPublic awareness: visibility and awareness of alzheimer's and dementia care are enhanced through strategic marketing and outreach efforts. Caregivers and families are informed about available resources and support to help navigate the complexities of care. Community engagement is fostered through media campaigns, public events like the annual walk and gala, and partnerships, ensuring the message reaches those in need. These efforts have expanded the impact, raising awareness and driving participation in essential services.
$680,921 spent15% of program spendingCommunity building & special populations: alzheimer's and cognitive disorders occur regardless of culture, race, ethnicity, language, socio-economic status, gender, sexual orientation, geography, etc. Providing accessible and equitable services to match needs regardless of one's background and in culturally sensitive ways is part of caringkind's ethos. The goal of the community building & special populations department is to increase the dementia awareness and friendliness of local communities to ensure families impacted by dementia have access to community supports and inclusive services that honor distinct populations, diverse backgrounds, experiences, preferences, cultures, languages, etc. Workforce development & consultingthe goal of the workforce development department is to build the capacity of healthcare systems, residential communities and long-term service and support providers to provide comprehensive and quality dementia care. Research caringkind recognizes that finding a cure and developing new and improved services for those impacted by alzheimer's and other cognitive disorders requires research and a large, diverse pool of willing, research participants. Caringkind…
$1,072,597 spentof which $74,064 as grants$36,074 earned by the program24% of program spending
The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $4,505,146.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $7.6M to $11M (+39%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 19% · 2022 19% · 2023 9% · 2024 6% · 2025 7%. Grants only. Government contracts and fees sit inside program revenue.
93% of ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Eleonora Carmen Tornatore
President & CEO
As listed on its FY2025 Form 990.
The chief executive listed changed between the FY2018 and FY2019 filings.
Who funds it, year by year
2017 → 2023: the base broadened from 42 funders to 63 funders, grant income fell $1.7M → $1.2M.
19 of 202 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 38% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC’s funders (the co-funder graph). Top 30 of 202 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC has a broad base — no single funder exceeds 14% of grant income, and it takes 7 funders to reach half.
the vertical line marks half of all grant income — 7 funders to its left
55% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC.
Largest funder’s share by year: 2017 67% · 2018 26% · 2019 17% · 2020 13% · 2021 13% · 2022 17% · 2023 22% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
35% of ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC's funders are still giving 3 years after their first grant; 43% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
74% of ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC's grant income comes from New York funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $3.8M arriving through sponsors registered in 14 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC's revenue fell 17% between 2017 and 2025.
this organization peer median middle 50% of peers· 4,665 health nonprofits $1M–$10M, FY2025
Government funding ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $1000k on record.
- Department of Health and Human Services$1000k
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
72% of spending goes to programs.
Governance
Public support
84%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 2 states
Screen this organization
A dated, signed PDF of the compliance screen for ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC?
- ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC (New York) receives grants from 202 organizations whose IRS filings report $9,875,540 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($1,402,243). 86 of them have funded it in more than one year.
- How many funders does ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC have?
- IRS filings report 202 organizations giving $9,875,540 in grants to ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC, 86 of which have funded it in more than one year.
- Who is the largest funder of ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $1,402,243 in grants. The full list of funders is on this page.
- How can an organization like ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 202 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing